Data

L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder:A Double-Blind Randomised Placebo-Controlled Trial (TAGS)

Western Sydney University
Sarris, Jerome ; Byrne, Gerard J ; Cribb, Lachlan ; Oliver, Georgina ; Murphy, Jenifer ; Macdonald, Patricia ; Nazareth, Sonia ; Karamacoska, Diana ; Galea, Samantha ; Short, Anika ; Ee, Carolyn ; Birling, Yoann ; Menon, Ranjit ; Ng , Chee H
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26183/y7w3-5b83&rft.title=L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder:A Double-Blind Randomised Placebo-Controlled Trial (TAGS)&rft.identifier=10.26183/y7w3-5b83&rft.publisher=Western Sydney University&rft.description=The objective of this trial is to assess the effectiveness and safety of L-theanine (an amino acid constituent of green tea [Camellia sinensis]) as an adjunctive therapy to treat GAD by conducting a phase II double-blind randomised controlled trial. It is hypothesised that L-theanine will be superior to placebo in reducing anxiety in participants with GAD. The dataset relates to the clinical trial ACTRN12616000759493 L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial. This data cannot be shared publicly due to ethics approval conditions. To discuss this data, please contact the NICM Health Research Institute nicm@westernsydney.edu.au.&rft.creator=Sarris, Jerome &rft.creator=Byrne, Gerard J &rft.creator=Cribb, Lachlan &rft.creator=Oliver, Georgina &rft.creator=Murphy, Jenifer &rft.creator=Macdonald, Patricia &rft.creator=Nazareth, Sonia &rft.creator=Karamacoska, Diana &rft.creator=Galea, Samantha &rft.creator=Short, Anika &rft.creator=Ee, Carolyn &rft.creator=Birling, Yoann &rft.creator=Menon, Ranjit &rft.creator=Ng , Chee H &rft.date=2025&rft.relation=http://doi.org/10.1016/j.jpsychires.2018.12.014&rft.coverage=&rft_rights=Copyright Western Sydney University&rft_subject=Anxiety&rft_subject=GAD&rft_subject= L-theanine&rft_subject=Randomised controlled trial&rft_subject=Sleep&rft_subject=Traditional, complementary and integrative medicine not elsewhere classified&rft_subject=Traditional, complementary and integrative medicine&rft_subject=HEALTH SCIENCES&rft_subject=Other health sciences not elsewhere classified&rft_subject=Other health sciences&rft_subject=Mental health&rft_subject=Public health (excl. specific population health)&rft_subject=HEALTH&rft_subject=Nutrition&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

view details

Copyright Western Sydney University

Access:

Restrictions apply view details

Restricted

Full description

The objective of this trial is to assess the effectiveness and safety of L-theanine (an amino acid constituent of green tea [Camellia sinensis]) as an adjunctive therapy to treat GAD by conducting a phase II double-blind randomised controlled trial. It is hypothesised that L-theanine will be superior to placebo in reducing anxiety in participants with GAD. The dataset relates to the clinical trial ACTRN12616000759493 L-Theanine in the Adjunctive Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial. This data cannot be shared publicly due to ethics approval conditions. To discuss this data, please contact the NICM Health Research Institute nicm@westernsydney.edu.au.

Created: 2025-04-01

Data time period: 12 09 2017 to 30 06 2018

This dataset is part of a larger collection

Identifiers
  • DOI : 10.26183/Y7W3-5B83
  • Local : research-data.westernsydney.edu.au/published/5dd3f5a0a61911efbb9db34536804e8c